Suppression of alloantigen-induced T-cell proliferation by CD14(+) cells derived from granulocyte colony-stimulating factor-mobilized peripheral blood mononuclear cells

被引:186
作者
Mielcarek, M [1 ]
Martin, PJ [1 ]
TorokStorb, B [1 ]
机构
[1] UNIV WASHINGTON,DEPT MED,SEATTLE,WA
关键词
D O I
10.1182/blood.V89.5.1629
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The proliferative responsiveness of granulocyte colony-stimulating factor (G-CSF)-mobilized blood was studied in uni-directional mixed leukocyte cultures. Unfractionated mononuclear cells from mobilized blood obtained by leukapheresis at day 4 after initiation of G-CSF (G-PBMC) were hyporesponsive (31.5%+/-9.2% response, P=.003) compared to mononuclear cells obtained from the peripheral blood before administration of G-CSF (preG-PBMC). There was great variability among donors when purified preG- and G-CD4 cells were compared, In eight of 10 donors, G-CD4 cells were equally responsive or moderately hyporesponsive; in two of 10 donors, G-CD4 cells were more strikingly hyporesponsive, CD14 cells derived from leukapheresis products (G-CD14 cells) suppressed alloantigen-induced proliferation by 48.6%+/-7.5% when added to preG-PBMC or preG-CD4 cells at responder-CD14 ratios of 2:1 (P <.001). Suppression was evident (14.4%+/-5.0%) even at responder-CD14 ratios of 8:1 and was largely contact-independent. PreG- and G-CD14 cells had equivalent potency in suppressing proliferative responses. Given that G-CSF-mobilized blood cell grafts contain 50-fold more CD14 cells and only 10-fold more T cells than marrow, we propose that suppression of donor T cells by the large proportion of monocytes present in leukapheresis products could contribute to the unexpectedly low incidence and severity of graft-versus-host disease after peripheral blood stem cell transplantation. (C) 1997 by The American Society of Hematology.
引用
收藏
页码:1629 / 1634
页数:6
相关论文
共 37 条
[1]  
BENSINGER W, 1993, BLOOD, V81, P3158
[2]   TRANSPLANTATION OF ALLOGENEIC PERIPHERAL-BLOOD STEM-CELLS MOBILIZED BY RECOMBINANT HUMAN GRANULOCYTE-COLONY-STIMULATING FACTOR [J].
BENSINGER, WI ;
WEAVER, CH ;
APPELBAUM, FR ;
ROWLEY, S ;
DEMIRER, T ;
SANDERS, J ;
STORB, R ;
BUCKNER, CD .
BLOOD, 1995, 85 (06) :1655-1658
[3]  
Bensinger WI, 1996, BLOOD, V88, P4132
[4]  
DREGER P, 1993, BLOOD, V81, P1404
[5]   ALLOSTIMULATORY CELLS IN FRESH HUMAN BLOOD - HETEROGENEITY IN ANTIGEN-PRESENTING CELL-POPULATIONS [J].
EGNER, W ;
ANDREESEN, R ;
HART, DNJ .
TRANSPLANTATION, 1993, 56 (04) :945-950
[6]  
GOTO S, 1991, TRANSPL P, V23, P2017
[7]  
GUINAN EC, 1994, BLOOD, V84, P3261
[8]   SEQUENTIAL HIGH-DOSE THERAPY WITH PERIPHERAL-BLOOD PROGENITOR-CELL SUPPORT IN LOW-GRADE NON-HODGKINS-LYMPHOMA [J].
HAAS, R ;
MOOS, M ;
KARCHER, A ;
MOHLE, R ;
WITT, B ;
GOLDSCHMIDT, H ;
FRUHAUF, S ;
FLENTJE, M ;
WANNENMACHER, M ;
HUNSTEIN, W .
JOURNAL OF CLINICAL ONCOLOGY, 1994, 12 (08) :1685-1692
[9]   CD28-MEDIATED SIGNALING CO-STIMULATES MURINE T-CELLS AND PREVENTS INDUCTION OF ANERGY IN T-CELL CLONES [J].
HARDING, FA ;
MCARTHUR, JG ;
GROSS, JA ;
RAULET, DH ;
ALLISON, JP .
NATURE, 1992, 356 (6370) :607-609
[10]  
KERNAN NA, 1986, BLOOD, V68, P770